SXTC

$1.80

Market ClosedAs of Mar 17, 8:00 PM UTC

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$1.80
Potential Upside
5%
Whystock Fair Value$1.89
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, an...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.54M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.74
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-50.30%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
4.04

Recent News

Associated Press Finance
Feb 2, 2026

BC-Most Active Stocks

Elong Power Holding Ltd. 31,796,929 2.31

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Aug 2, 2025

China SXT Pharmaceuticals Full Year 2025 Earnings: US$2.32 loss per share (vs US$28.58 loss in FY 2024)

China SXT Pharmaceuticals ( NASDAQ:SXTC ) Full Year 2025 Results Key Financial Results Revenue: US$1.74m (down 9.7...

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Simply Wall St.
Jul 31, 2025

US Market's Undiscovered Gems Featuring 3 Promising Stocks

As the United States market continues to experience robust economic growth and strong corporate earnings, major indices like the S&P 500 and Nasdaq Composite are reaching new heights, driven by optimism despite lingering tariff concerns. In this dynamic environment, identifying promising stocks requires a keen eye for companies that demonstrate resilience and potential for growth amid broader market trends.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Jul 31, 2025

Undiscovered Gems in the US Market for July 2025

Over the last seven days, the United States market has remained flat, yet it has seen a significant 16% increase over the past year with expectations of earnings growing by 15% annually in the coming years. In this dynamic environment, identifying stocks that are not only resilient but also poised to capitalize on growth opportunities can be key to uncovering potential undiscovered gems.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Jul 29, 2025

US Undiscovered Gems with Strong Potential July 2025

As the S&P 500 and Nasdaq Composite continue to reach new highs, fueled by strong corporate earnings and easing tariff concerns, investors are closely watching the Federal Reserve's upcoming meeting on interest rates. This environment of optimism and economic resilience presents a fertile ground for identifying promising opportunities among small-cap stocks. In this context, discovering stocks with solid fundamentals and growth potential can be particularly rewarding, as they may offer unique...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.